MedTrace Logo

PRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot Ulcer

NCT03248466 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-08-14

No results posted yet for this study

Summary

To investigate the treatment effect between Traditional treatment and transplantation of autologous PRG combined with autologous BMMSCs for treatment of diabetic foot ulcer.

Conditions

  • Diabetic Foot Ulcer

Interventions

BIOLOGICAL

PRG combined with BMMSCs transplantation

PRG combined with BMMSCs transplantation

Sponsors & Collaborators

  • Third Military Medical University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-30
Primary Completion
2020-01-01
Completion
2020-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03248466 on ClinicalTrials.gov